Nathan Rice
Stock Analyst at Piper Sandler
(1.32)
# 1443
Out of 5,319 analysts
59
Total ratings
44.83%
Success rate
11.83%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BFC Bank First | Maintains: Neutral | 110 111 | 106.3 | 4.42% | 6 | Apr 17, 2025 | |
MBIN Merchants Bancorp | Maintains: Overweight | 53 57 | 32.52 | 73.74% | 7 | Jan 30, 2025 | |
FMBH First Mid Bancshares | Maintains: Overweight | 46 47 | 32.32 | 45.42% | 3 | Nov 1, 2024 | |
BY Byline Bancorp | Reiterates: Overweight | 34 34 | 24.18 | 40.61% | 8 | Oct 29, 2024 | |
CVS CVS Health | Maintains: Buy | 85 74 | 67.29 | 9.97% | 2 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 84 | 110.82 | -24.2% | 1 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 197 | 171.41 | 14.93% | 8 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 11 9 | 8.44 | 6.64% | 1 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 40 | n/a | n/a | 1 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 530 435 | 411.49 | 5.71% | 4 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 233 | 330.13 | -29.42% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 83 | 60.7 | 36.74% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 15 | 14.78 | 1.49% | 1 | Dec 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 49 54 | n/a | n/a | 4 | Feb 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 31 | n/a | n/a | 2 | Jul 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Jul 24, 2017 |